Dear friends and colleagues,
On behalf of the Programme Committee, I invite you to attend the inaugural Imaging in Neuromuscular Disease Conference organized by the MYO-MRI consortium. This international conference will be held in Berlin from Sunday 19th to Tuesday 21st of November 2017.
The conference program will feature internationally-recognized keynote speakers highlighting developments and advances in all aspects of muscle imaging. At least 200 participants from the neuromuscular field are expected to attend. Key note speakers include Andrew Blamire, Carsten Bonnemann, Pierre Carlier, Bruce Damon, Kieren Hollingsworth, Hermien Kan, Richard Lerski, Martin Meyerspeer, George Radda, Fritz Schick, Volker Straub, Gustav Strijkers, Giorgio Tasca, Krista Vandenborne and Felix Wehrli.
The Imaging in Neuromuscular Disease Conference will be organized by the MYO-MRI project, a consortium supported by COST, the European Cooperation in Science and Technology. MYO-MRI focusses on applications of MR imaging and spectroscopy techniques in neuromuscular disease and has enabled collaboration on MRI as an outcome measure and on pattern recognition for diagnostics and therapy development. The project has addressed the challenges of applying MR techniques in both clinical trials and everyday clinical settings.
The Imaging in Neuromuscular Diseases Conference will highlight key findings from MYO-MRI and will discuss next steps of interest to academia and industries.
The programme will feature plenary talks on the following topics; Diagnostic Muscle Imaging, New Imaging Techniques and Quantitative Muscle Imaging – with plenary sessions and invited abstracts on each.
You are cordially invited to be part of this inaugural international conference which I think will provide the opportunity to forge new partnerships, learn from the leading and brightest minds in the field and share best practices with leading experts.
We are looking forward to welcoming you in Berlin.
Chair, Programme Committee
For further enquiries or to discuss sponsorship opportunities, please contact: Helen Sutherland